Referred for management of mastocytosis

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 1, 1997, Pages 21-26

  Apter, Andrea J ^a   Rothe, Marti J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HYPERPIGMENTATION; MAST CELL; MASTOCYTOSIS; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0030795282     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63079-7     Document Type: Article

References (14)

1. Metcalfe DD, ed. Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. J Invest Dermatol 1991;96:1S-65S.
2. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case 7-1992. N Engl J Med 1992;326:472-82.
3. Duffy TP. Clinical problem solving: getting the story straight. N Engl J Med 1993;328:1333-6.
4. Austen KF. Systemic mastocytosis. N Engl J Med 1992;326:639-40.
5. Schwartz LB, Metcalfe DD, Miller JS, et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-6.
6. Schwartz LB, Bradford TR, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994;14:190-204.
7. Schwartz LV, Sakai K, Bradford TR, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-10.
8. Sehgal VN, Gangwani OP. Fixed drug eruptions. Int J Dermatol 1987;26: 67-73.
9. Korkij W, Soltani K. Fixed drug eruption, a brief review. Arch Dermatol 1984;520-4.
10. Deswarte RD. Drug allergy. In: Patterson R, Grammer LC, Greenberger PA, Zeiss CR, eds. Allergic diseases: Diagnosis and management, 4th edition. Philadelphia: Lippincott, 1993:443.
11. Fujimoto Y, Hawakawa R, Suzuki M, Ogino Y. Fixed drug eruption due to allylisopropyl acetylurea. Contact Dermatitis 1993;28:282-4.
12. Bruynzeel DP, van Ketel WG. Patch testing in drug eruptions. Seminars in Dermatology 1989;8:196-203.
13. Fritsch PO, Elias PM. Erythema multiforme and toxic epidermal necrolysis. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. Dermatology in general medicine, 4th edition. New York: McGraw Hill, 1993:585-600.
14. St. Clair K, Duvic M. Erythema multiforme. Intern Med Specialist 1987;8: 113-5,119-20,123-5,129-32.